Understanding Health Insurance Coverage for SYMPHONY™ in the USA

Agendia’s mission is to provide all breast cancer patients access to Agendia’s Symphony™ Breast Cancer Decision Suite, which includes, MammaPrint^®, BluePrint™, TargetPrint^®, and TheraPrint^®, to help physicians and patients make more informed, personalized therapy decisions. Agendia understands that costs associated with the patient’s diagnosis, treatment, and management of their breast cancer can possibly pose a financial hardship and may influence a patient’s decision in selecting diagnostic and treatment options.

Agendia has established coverage for Symphony breast cancer tests and is billing insurance companies on behalf of insured patients throughout the United States. Based on the patient’s specific benefit level, the insurance companies will pay a portion or all of the cost submitted for the Symphony tests.  Patients are responsible for their co-insurance, co-pay, or deductible per their health insurance plan. For more information about medical insurance coverage questions, please review the Frequently Asked Questions (FAQ's) page.

Agendia is a compassionate company offering a wide range of financial assistance programs based on individual financial status. Agendia’s Reimbursement Assistance Program (ARAP) includes the following to meet the patient’s financial needs:

• Uninsured patient assistance
• Indigent patient assistance
• Underinsured patient assistance
• Interest-free payment plans
  
  

Agendia remains dedicated to providing physicians and their patients the very best in diagnostic testing and customer support. For questions regarding a patient’s specific level of coverage, please contact Agendia:

e:  billing@agendia.com